SPHK1 and pulmonary fibrosis: We reasoned that SPHK1 inhibition by PF543 administered following exposure to a fibrogenic agent will afford substantial protection against lung fibrosis by reducing AEC mtDNA damage and recruitment of Mo-AMs.